| Date | Title | Description |
| 19.09.2024 | A New Dawn in Kidney Cancer Treatment: Roswell Park's Breakthrough Regimen | In the realm of cancer treatment, hope often flickers like a candle in the dark. But recent findings from Roswell Park Comprehensive Cancer Center have ignited a brighter flame for patients battling metastatic kidney cancer. At the European... |
| 18.09.2024 | Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI | TAIPEI and SAN DIEGO, Sept. 18, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), , a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that an I... |
| 15.09.2024 | Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer | Roswell Park's Saby George, MD, presented study findings highlighting a treatment combination shown to extend survival in patients with advanced kidney cancer.
During the European Society for Medical Oncology (ESMO) Congress, Saby George, M... |
| 14.09.2024 | Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation | ROCKVILLE, Md. and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily... |
| 11.09.2024 | Pioneering Cancer Treatments Take Center Stage at ESMO 2024 | The European Society of Medical Oncology (ESMO) Congress 2024 is set to be a pivotal event in the world of oncology. From September 13 to 17, Barcelona will host a gathering of minds, all focused on the latest breakthroughs in cancer treatm... |
| 10.09.2024 | Revolutionizing Healthcare: The Dawn of AI and Innovative Sterilization Solutions | In the fast-paced world of healthcare, innovation is the lifeblood that keeps the industry thriving. Two recent breakthroughs illustrate this trend: the FDA clearance of the CADDIE™ AI endoscopy system and the EO Chex™ ethylene oxide indica... |
| 09.09.2024 | ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress | ROCKVILLE, Md. and SUZHOU, China, Sept. 9, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for malign... |
| 05.09.2024 | First Cloud-Based AI Endoscopy System for Colonoscopy Receives FDA Clearance | Leveraging the power of the cloud and AI to improve clinical outcomes
CENTER VALLEY, Pa., Sept. 5, 2024 /PRNewswire/ -- Odin Medical Ltd., an Olympus Corporation company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance... |
| 04.09.2024 | Transforming Healthcare: Data Analytics, ML & AI in Effective Cancer Recurrence Prediction | Created by Carl Williams
Sep 04 2024, 01:04 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 30.08.2024 | Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed New Director of Institute for Genome Sciences | Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment
BALTIMORE, Aug. 30, 2024 /PRNewswire/ -- Elana J. Fertig, PhD, FAIMBE
University of Maryland School of Medicine (UMSOM) Dean Mar... |
| 29.08.2024 | Technology Showcase highlights life science opportunities in Frederick, Maryland | Networking Opportunity at Tech Showcase
Frederick's economic development teams to partner with National Cancer Institute and Frederick National Laboratory on annual event for biotech stakeholders
FREDERICK, Md., Aug. 29, 2024 /PRNewswire-PR... |
| 21.08.2024 | Pioneering Progress in Pediatric Oncology and Healthcare Analytics | In the ever-evolving landscape of healthcare, two recent breakthroughs shine a light on the potential for innovation to transform patient outcomes. Phrase Health, a trailblazer in electronic health record (EHR) workflow management, has secu... |
| 15.08.2024 | Children's Hospital of Philadelphia Researchers Reveal New Hope for Chemotherapy-Resistant Neuroblastoma Patients | Study is the first to identify malignant cells responsible for relapse in high-risk neuroblastoma
PHILADELPHIA, Aug. 15, 2024 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) announced a significant breakthrough in ... |
| 14.08.2024 | Halda Therapeutics: A New Dawn in Cancer Treatment | In the relentless battle against cancer, drug resistance often feels like a formidable fortress. Standard treatments, while effective for many, frequently fall short as tumors evolve and adapt. This is where Halda Therapeutics enters the fr... |
| 13.08.2024 | Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE | ROCKVILLE, Md. and SUZHOU, China, Aug. 13, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies for ma... |
| 13.08.2024 | SITC Announces Fireside Chat with Dr. Kim Rathmell and Dr. Leisha Emens at its 39th Annual Meeting | SITC 2024 logo
The Society for Immunotherapy of Cancer (SITC) has the pleasure of hosting a prestigious fireside chat featuring two distinguished figures in the field of cancer and immuno-oncology: Kim Rathmell, MD, PhD, Director of the Nat... |
| 12.08.2024 | Halda Therapeutics raises $126M to overcome drug resistance in cancer | The company will start clinical trials for prostate cancer, and develop a breast cancer therapeutic
Drug resistance to standard treatments is common in metastatic cancer: some reasons for this include tumor heterogeneity where cancer cells ... |
| 12.07.2024 | There’s a rare and devastating cancer affecting young adults: One woman’s tips on how to cope with a difficult diagnosis | (BPT) - Sponsored by Adaptimmune Therapeutics.
Megan was 12 years old, an active student-athlete, and an enthusiastic member of her cheerleading squad when she first started experiencing what she described as a “weird zing” of pain in her r... |
| 11.07.2024 | Cancer Patient Finds Voice Again After US' Third Successful Larynx Transplant | By John Lopez
Published Jul 11, 2024 8:56AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
A Massachusetts man has regained his voice after a successful larynx transplant performe... |
| 10.07.2024 | Can Aperol Spritz Increase Cancer Risk? Here’s What Studies Say | By Quincy Jon
Published Jul 10, 2024 1:21PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
Whether Aperol Spritz can increase the risk of cancer or not has been a hot topic online... |
| 08.07.2024 | Olverembatinib Approved for Commercialization in Macau China | ROCKVILLE, Md. and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies for hematological m... |
| 05.07.2024 | Health | 10 sunscreen myths you can’t afford to fall for | Sunscreens can protect you from these malignancies in one of two ways. Chemical sunscreens contain ingredients such as avobenzone that absorb UV rays. Mineral sunscreens rely on zinc oxide or titanium dioxide to block or reflect the rays. E... |
| 04.07.2024 | Breakthrough in Cancer Treatment: SCG Cell Therapy's Next-Generation HPV-Specific TCR T Cell Therapy | SCG Cell Therapy, a biotech company, has received FDA clearance for SCG142, a cutting-edge TCR T cell therapy for HPV-associated solid tumors. This innovative treatment shows promise in revolutionizing cancer care.
SCG Cell Therapy's SCG142... |
| 04.07.2024 | Ascentage Pharma Received US$100 Million Option Payment from Takeda | ROCKVILLE, Md. and SUZHOU, China, July 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematol... |
| 01.07.2024 | SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors | SINGAPORE, July 1, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (F... |
| 30.06.2024 | SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors | SINGAPORE, June 30, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (... |
| 26.06.2024 | For healthy adults, taking multivitamins daily is not associated with a lower risk of death | Findings come from an NIH analysis of more than two decades of dietary data from 390,124 U.S. adults.
BETHESDA, Md., June 26, 2024 /PRNewswire/ --
What: A large analysis of data from nearly 400,000 healthy U.S. adults followed for more than... |
| 25.06.2024 | CUNY SPH receives $5.2 million NIH grant renewal for cancer genomics research | NEW YORK, June 25, 2024 /PRNewswire/ -- The Informatics Technology for Cancer Research (ITCR) program of the NIH National Cancer Institute has awarded the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) a competitive rene... |
| 19.06.2024 | Cooperman Barnabas Medical Center Announces Historic Gift from Andrea and Anthony Melchiorre to Support New Cancer Center | Multidisciplinary Facility to be named the Melchiorre Cancer Center at Cooperman Barnabas Medical Center
LIVINGSTON, N.J., June 19, 2024 /PRNewswire/ -- Cooperman Barnabas Medical Center (CBMC), an RWJBarnabas Health facility, has received ... |
| 11.06.2024 | AI Program Accurately Diagnoses Common Lung Cancer From Tissue Images | By John Lopez
Published Jun 11, 2024 9:35AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
In a recent study published in Nature Communications, researchers from NYU Langone Healt... |
| 06.06.2024 | I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer | ROCKVILLE, Md., June 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapi... |
| 04.06.2024 | UChicago joins multisite study to improve health of Asian Americans, Native Hawaiians and Pacific Islanders | The University of Chicago is among five clinical sites conducting a first-of-its-kind study aimed at uncovering risk factors and targeted interventions to better prevent disease in Asian Americans, Native Hawaiians and Pacific Islanders (As... |
| 03.06.2024 | NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy | BETHESDA, Md., June 3, 2024 /PRNewswire/ --
What: In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a s... |
| 03.06.2024 | Кто будет разрабатывать лекарства? | Появление новых лекарств — всегда ожидаемое событие. Несмотря на широкомасштабные исследования фармкомпаний эффективных средств по–прежнему не хватает. В среднем на разработку одного препарата уходит 10–15 лет и около 2,5 млрд долларов — эт... |
| 31.05.2024 | New Lung Cancer Drug Halts Disease Progression Longer Than Ever Before | By John Lopez
Published May 31, 2024 11:22AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
A groundbreaking development in lung cancer treatment has emerged with the first trial ... |
| 29.05.2024 | BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development | BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development
Wed, May 29, 2024 07:00 CET Report this content
Bergen, Norway, May 29, 2024 – BerGenBio ASA (OSE: BGBIO), a clinical-stage bio-pharmaceutical company developi... |
| 27.05.2024 | Dato-DXd improved OS in nonsquamous lung cancer | Dato-DXd improved OS in nonsquamous lung cancer
Mon, May 27, 2024 08:00 CET Report this content
This announcement contains inside information
27 May 2024
Datopotamab deruxtecan showed clinically meaningful overall survival
improvement vs. c... |
| 23.05.2024 | How a 28-Year-Old Woman Kept Her Sense of Adventure Following a Rare Disease Diagnosis | (BPT) - In 2018, a vibrant young woman with a passion for theater and education set off on the quest of a lifetime: spending a month walking 500 miles on the Camino de Santiago pilgrimage from France to Spain. Christina K. was also at the b... |
| 20.05.2024 | AI Speeds Up Brain Tumor Classification with 95% Accuracy: Study | By Quincy Jon
Published May 20, 2024 1:59PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
Australian and US researchers highlight their artificial intelligence (AI) technology th... |
| 16.05.2024 | Health | What’s keeping the US from allowing better sunscreens? | In a rare example of bipartisanship last summer, Sen. Mike Lee, R-Utah, thanked Rep. Alexandria Ocasio-Cortez (D-N.Y.) for urging the FDA to speed up approvals of new, more effective sunscreen ingredients. Now a bipartisan bill is pending i... |
| 16.05.2024 | Higher rates of cancer in minoritized communities across Chicago and U.S. driven by disparities | In June 2023, residents of Hyde Park and surrounding communities were invited to the DuSable Museum of Black History to learn about cancer risk and prevention at a health fair, one of UChicago Medicine's initiatives to promote cancer equity... |
| 13.05.2024 | Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results | Quarterly EsoGuard® test volume increased 10 percent
Strengthened balance sheet following completion of $29.8 million Series B Preferred Stock Offering
MolDX pre-submission meeting scheduled for July 17, 2024
Conference call and webcast to ... |
| 13.05.2024 | Health | Breakthrough therapies are saving lives. Can we afford them? | The prices aren’t yet unmanageable, because so few people are currently treated. Patients must travel to designated treatment centers, and too few are referred by community physicians. But demand should increase as more treatments are intro... |
| 08.05.2024 | Strengthening CAR-T Therapy to Work Against Solid Tumors | BRONX, N.Y., May 8, 2024 /PRNewswire/ -- Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to tre... |
| 03.05.2024 | Mystery risk factor linked to high rates of kidney cancer, major DNA study finds | Researchers analysing the DNA of people with kidney cancer worldwide have found evidence of an unknown trigger that could explain the longstanding mystery of why some countries* have a higher incidence of the disease.
In a paper published t... |
| 26.04.2024 | Analysis identifies 50 new genomic regions associated with kidney cancer risk | Researchers have identified 50 new regions across the genome that are associated with the risk of developing kidney cancer.
Credit: iStock/libre de droit What
In a new analysis of genetic susceptibility to kidney cancer, an international te... |
| 16.04.2024 | Precision for Medicine Renews and Expands at Riverside Tech Park to Occupy over 116,000 Square Feet | St. John Properties Inc.
Clinical development company signs new 41,040 square foot lease at 8440 Broadband Drive
FREDERICK, Md. , April 16, 2024 /PRNewswire-PRWeb/ -- Clinical development company Precision for Medicine, LLC has signed renew... |
| 15.04.2024 | Метаболизм и долголетие. Личный опыт | Этот текст - логическое продолжение описания моего инженерного подхода в вопросе долголетия. Если вы не читали предыдущую статью, то рекомендую ознакомиться. Текущая же статья потребует 10 минут вашего внимания, но может добавить 10 лет к в... |
| 12.04.2024 | Michael Pollan says broccoli is better than any supplement — here's why | Health Michael Pollan says broccoli is better than any supplement — here's why
Hilary Brueck
2024-04-12T13:03:15Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. It indicates the... |
| 12.04.2024 | SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series | AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series
The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving patient outcomes by advancing the science and application ... |
| 08.04.2024 | Enhertu approved in US for HER2+ solid tumours | Enhertu approved in US for HER2+ solid tumours
Mon, Apr 08, 2024 08:00 CET Report this content
08 April 2024
Enhertu approved in the US as first tumour-agnostic HER2-directed therapy
for previously treated patients with metastatic HER2-posi... |
| 08.04.2024 | Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients | Roswell Park Chair of Thoracic Surgery Dr. Sai Yendamuri will present his team’s latest findings on lung cancer and obesity during a major symposium at AACR 2024.
Obesity is associated with a higher risk of developing at least 13 types of c... |
| 08.04.2024 | Allterum Therapeutics receives $12 million product development grant from CPRIT to advance anti-CD127 therapeutic antibody into clinic | Allterum Therapeutics is a Fannin company
Allterum Therapeutics, Inc. has been awarded a $12 million product development grant from the Cancer Prevention and Research Institute of Texas (CPRIT). This grant will support the clinical evaluati... |
| 05.04.2024 | Imfinzi improved OS & PFS in limited-stage SCLC | Imfinzi improved OS & PFS in limited-stage SCLC
Fri, Apr 05, 2024 08:00 CET Report this content
05 April 2024
Imfinzi significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung ... |
| 31.03.2024 | Tesla's Heartwarming Gesture: Delivering Cybertrucks to Cancer Patients | Inno Flores, Tech Times 31 March 2024, 11:03 pm
Amidst the challenges of battling stage 4 cancer, a member of the Cybertruck Owners Club shared a poignant request. Fulfilling a heartfelt wish, Tesla brings joy to a cancer patient's life wit... |
| 28.03.2024 | Texas Space Commission launches, Houston execs named to leadership | Governor Greg Abbott announced the Texas Space Commission, naming its inaugural board of directors and Texas Aerospace Research and Space Economy Consortium Executive Committee.
The announcement came at NASA's Johnson Space Center, and the ... |
| 28.03.2024 | City of Houston approves $13M for new security tech at renovated IAH terminal | A new terminal currently under construction at George Bush Intercontinental Airport just got the green light for new security technology.
This week, Houston City Council unanimously approved the funding for the new Mickey Leland Internation... |
| 22.03.2024 | House approves $1.2T spending package before shutdown deadline | ASSOCIATED PRESS
Speaker of the House Mike Johnson, R-La., speaks at the Capitol in Washington, on Wednesday. The House approved a $1.2 trillion package of spending bills today just a few hours before funding for some key federal agencies i... |
| 14.03.2024 | Health | Studying use of patients’ own reprogrammed cells to attack cancer as alternative to more chemo | A process of taking patients’ own cells and reprogramming them to fight cancer has been a last-ditch option for blood cancer patients when nothing else worked, but a new study underway in Aurora is trying to determine whether more patients ... |
| 12.03.2024 | Health | Fluoride in public water has slashed tooth decay, but some states may end mandates | Robbie Sequeira | (TNS) Stateline.org
Kentucky state Rep. Mark Hart has been drinking fluoridated water his entire life. In 1954, five years before Hart was born, his home state mandated adding or adjusting levels of the mineral, which occu... |
| 07.03.2024 | DLH to Provide Information Technology Services to the National Cancer Institute | - |
| 04.03.2024 | Reglagene Expands to Houston and Joins TMC's Accelerator for Cancer Therapeutics | Reglagene's RGN6024 is on track to give new hope to provide orally administered therapy for brain cancer patients whose survival has historically been very low.
Will speed development of RGN6024 therapy into the clinic
This is a exciting. A... |
| 22.02.2024 | A woman with unexplained bleeding felt dismissed by her gynecologist. She swapped doctors and was diagnosed with cervical cancer. | Health A woman with unexplained bleeding felt dismissed by her gynecologist. She swapped doctors and was diagnosed with cervical cancer.
Serafina Kenny
2024-02-22T10:33:51Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The ... |
| 21.02.2024 | NIH launches research network to evaluate emerging cancer screening technologies | The Cancer Screening Research Network will evaluate emerging technologies for cancer screening, such as blood tests that can screen for several types of cancer.
Credit: iStock
The National Institutes of Health (NIH) has launched a clinical ... |
| 06.02.2024 | Stomach cancer symptoms and risk factors to know following Toby Keith's death | Country music star Toby Keith has died at 62 after previously revealing he was undergoing treatment for stomach cancer.
A statement on Keith's social media and website announced early Tuesday that he "passed peacefully last night on Fe... |
| 05.02.2024 | An influencer who faked her death from cervical cancer says she did it to raise awareness for women who actually died from the disease | News An influencer who faked her death from cervical cancer says she did it to raise awareness for women who actually died from the disease
Katie Balevic
2024-02-04T21:08:21Z
Share icon An curved arrow pointing right.
Share
Facebook Icon Th... |
| 18.01.2024 | Health | Hoping to clear the air in casinos, workers seek to ban tobacco smoke | Sandy West | KFF Health News (TNS)
The instant Tammy Brady felt the lump in her breast in February 2022, she knew it was cancer. With no known genetic predisposition for breast cancer, she suspects 38 years of working in smoky Atlantic City... |
| 13.01.2024 | The Crucial Role of Cervical Cancer Screening in Women's Health | Dr. Kameelah Phillips, M.D.
MARLBOROUGH, MASSACHUSETTS, UNITED STATES, January 12, 2024 /EINPresswire.com/ -- Recent studies have shown a concerning trend in cervical cancer rates among women under 50, with a sharp increase in cases among t... |
| 10.01.2024 | Adan Canto's wife breaks silence after his death from cancer at age 42: "Forever my treasure Adan" | The wife of actor Adan Canto posted a touching tribute to her late husband following his death this week at age 42 after a battle with appendiceal cancer.
"'Do not lay up for yourselves treasures on earth, where moth and rust destroy a... |
| 19.12.2023 | 7 research-backed tips to help you live longer | Health 7 research-backed tips to help you live longer
Ariel Schwartz
2023-12-19T18:14:18Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. It indicates the ability to send an emai... |
| 11.12.2023 | Finding Community, Finding Hope: Navigating Metastatic Breast Cancer | (BPT) - Facing a health crisis was the furthest thing from Melissa’s mind when she discovered her breast cancer. She was only 38 years old and a busy grad student living in Hawaii. “I was going for my masters in planetary geology, studying ... |
| 04.12.2023 | A well-meaning FDA policy is a threat to pediatric cancer treatment | The medical community today faces a deceptively simple question: How quickly should we act when a child’s life is on the line? I’m a pediatric oncologist, so my answer won’t surprise you — I think we should act immediately. But a new Food a... |
| 28.11.2023 | FDA Approval of SpringWorks Drug Is the First for Rare Connective Tissue Tumor | A SpringWorks Therapeutics drug has won FDA approval for treating a rare connective tissue tumor, making it the first approved therapy for this type of tumor. It’s also the first product approval for the Pfizer spinout.
Desmoid tumors are s... |
| 26.11.2023 | Health | She was diagnosed with breast cancer at 22. This Coloradan wants young women to know their risk. | Devon Brown knew not to ignore it when she found a lump in her breast that just didn’t seem quite right.
“It felt very round and hard, so that was pretty abnormal,” she said.
A biopsy confirmed she was right to worry: the lump was cancerous... |
| 25.11.2023 | Do I need to worry about smartphone radiation? Why are there still concerns over safety? | Listen to this article
Do I need to worry about smartphone radiation? Why are there still concerns over safety?
1 min
New: You can now listen to articles.
Sorry, the audio is unavailable right now. Please try again later.
This audio is gene... |
| 16.11.2023 | Progress in childhood cancer has stalled for Blacks and Hispanics, report says | Advances in childhood cancer are a success story in modern medicine. But in the past decade, those strides have stalled for Black and Hispanic youth, opening a gap in death rates, according to a new report published Thursday.
Childhood canc... |
| 25.10.2023 | Detección de cáncer de mama: el termograma no sustituye a la mamografía | La termografía no debe utilizarse en lugar de la mamografía, la cual sigue siendo la herramienta más eficaz para detectar el cáncer de mama.
Image
Caption La mamografía (L) son unos rayos X del seno que puede identificar tipos de tejido con... |
| 24.10.2023 | NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation | Steven A. Rosenberg, M.D., Ph.D., is a recipient of the 2023 National Medal of Technology and Innovation.
Credit: National Institutes of Health What
Immunotherapy pioneer Steven A. Rosenberg, M.D., Ph.D., has been awarded the National Medal... |
| 17.10.2023 | Breast cancer is deadlier for Black women. A study of mammograms could help close the gap | Are 3D mammograms better than standard 2D imaging for catching advanced cancers?
A clinical trial is recruiting thousands of volunteers — including a large number of Black women who face disparities in breast cancer death rates — to try to ... |
| 14.10.2023 | Inflation Reduction Act’s Drug Pricing Provisions May Lead To Lower Prices In Oncology | The high price of cancer drugs has led to usage of the term "financial toxicity" to describe the ... [+] cost burden on patients. Even where there are multiple competitors in an class of oncology medicines, branded (and some gener... |
| 26.09.2023 | Vitamin D is the antiaging supplement of choice for scientists and longevity investors | Health Vitamin D is the antiaging supplement of choice for scientists and longevity investors
Hilary Brueck
2023-09-26T19:52:14Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. I... |
| 15.09.2023 | Max Planck Humboldt Research Award Winner Researches Key Mechanisms of the Bacterial Immune System with Würzburg Helmholtz Institute and Ludwig Maximilian University of Munich | Rotem Sorek from the Weizmann Institute of Science in Israel will receive the Max Planck-Humboldt Research Award 2023, which is presented together with 1.5 million euros in prize money, in acknowledgement for his research into bacterial def... |
| 14.08.2023 | NCI unveils comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries | The comprehensive proteogenomic dataset could enable many new cancer research discoveries.
Credit: iStock What
The National Institutes of Health is releasing a comprehensive dataset that standardizes genomic, proteomic, imaging, and clinica... |
| 19.07.2023 | What's the link between sugar and cancer? Does avoiding sweets help fight the disease? | During the eight years Stacy Shawhan has worked as an oncology dietitian, she has heard many questions from her cancer patients about how their diets influence their prognosis. But one question has come up more than the rest: Will consuming... |
| 13.07.2023 | WHO declares aspartame "possibly carcinogenic." Here's what to know about the artificial sweetener. | The World Health Organization has declared aspartame, a common artificial sweetener used in thousands of products, to be "possibly carcinogenic to humans" — while also noting that "safety is not a major concern" in the q... |
| 12.07.2023 | Insights Management: A New Paradigm for Cancer Treatment | Lance Hill, CEO of Within3
The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027, life science companies are aligning efforts to prioritize t... |
| 30.06.2023 | Five New University Centers To Study Cancer Disparities In High Poverty Areas | The University of Texas MD Anderson Cancer Center is one of five new, federally funded Centers for ... [+] Cancer Control Research in Persistent Poverty Areas.getty |
| 29.06.2023 | University Of Kansas Receives Record $100 Million For Cancer Center | The University of Kansas Cancer Center has received a record-breaking $100 million gift to build a ... [+] new cancer center. (AP Photo/Charlie Riedel)Copyright 2020 The Associated Press. All rights reserved |
| 29.06.2023 | Does aspartame have health risks? What to know about the sweetener as WHO raises safety questions. | Aspartame, an artificial sweetener 200 times as potent as regular granulated sugar, is used in thousands of products on grocery store shelves, from sodas and drink mixes to low-cal condiments and desserts. Yet some consumers and researchers... |
| 29.06.2023 | Health
Health | Bladder cancer: What you should know about diagnosis, treatment and recurrence | Jessica Saenz | (TNS) Mayo Clinic News Network
Bladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It’s also one of the most likely types of cancer to recur.
Experts are developing ... |
| 28.06.2023 | Gleamer, which provides AI software for radiologists, raises $29.5M | Gleamer, a five-year-old French startup that has developed AI software to help radiologists diagnose and detect bone trauma lesions in scans, among other conditions, has raised €27 million ($29.5 million) in a Series B round of funding.
Fou... |
| 27.06.2023 | AI Tool Shows Promising Results in Identifying Sperm for Severely Infertile Men | John Lopez, Tech Times 27 June 2023, 04:06 pm
Infertility affects millions of couples in the United States, with male infertility accounting for a significant portion of cases. In fact, Cleveland Clinic reports that 10% of all males in the ... |
| 26.06.2023 | Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening | Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT
/EIN News/ --
(Prof. Dennis Lo and Danny Yeung at Signing Ceremony)
- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo.
- Insight... |
| 26.06.2023 | Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening | Company will Host Conference Call to Discuss the Transaction
on June 26 at 8:30 a.m. EDT
- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo.
- Insighta is powered by technology developed by the Centre for Novostics whi... |
| 15.06.2023 | Helocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program | - |
| 15.06.2023 | Brain Cancer Patients Enrolling in Phase 3 Clinical Trial of Promising Drug for Rare Brain Tumor | First Viable Option to Treat Rare Brain Tumor, most often found in children
We are very hopeful as we proceed that this trial will be pivotal in establishing a new treatment for patients with this rare brain tumor.”
— Neuro-oncologist Akank... |
| 08.06.2023 | The AI Revolution in Oncology: Pioneering Advances in Cancer Diagnosis and Treatment | Czech Republic ~
Cancer has posed a formidable challenge to both medical professionals and population throughout history. However, with the gradual advancements of artificial intelligence in healthcare, the field of oncology is awaiting a p... |
| 07.06.2023 | Want to help with medical breakthroughs? Donate some extra cells to a biobank | Right now, it’s possible that cells from my body are growing in a lab somewhere and are being used to test new cancer drugs.
After I was diagnosed with neuroendocrine tumors, a rare type of cancer, I went through surgery to remove the tumor... |
| 02.06.2023 | Imfinzi improved pCR in gastric and GEJ cancers | Imfinzi improved pCR in gastric and GEJ cancers
Fri, Jun 02, 2023 18:00 CET Report this content
2 June 2023
Imfinzi plus chemotherapy significantly improved pathologic complete response in gastric and gastroesophageal junction cancers in MA... |
| 31.05.2023 | Newly diagnosed cancer patients need help navigating the system | “Hey, I’m sorry to bother you, but I could really use your advice on something.”
As fellows in oncology training programs, we’re both accustomed to fielding texts, emails, and calls that start out like the above from family, friends, and ac... |